Nublexa Tablet
By Nublexa
Rx
28 Tablet in a Strip

Composition
Regorafenib(40mg)

Manufacturer - Bayer Zydus Pharma Pvt Ltd
Bayer House, Central Avenue, Hiranandani Estate, Thane (west) Thane 400607 India

Expires on or after
May, 2026

liver
When using Nublexa Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment, so it's vital to consult your doctor before starting this medication. Regular monitoring of liver function tests is recommended while taking Nublexa Tablet to ensure your liver health is maintained. Patients with severe liver disease are advised against using Nublexa Tablet. If you have any concerns regarding your liver health, make sure to seek guidance from your healthcare provider.

kidney
Nublexa Tablet is considered safe for use in patients with kidney disease. No dose adjustment is necessary. However, there is limited information on its use in patients with severe kidney disease.

alcohol
Consult your doctor when consuming alcohol with Nublexa Tablet.

driving
When taking Nublexa Tablet, avoid driving if you notice any symptoms that may impact your focus and reaction time. It's uncertain if Nublexa Tablet affects driving ability.

pregnancy
Nublexa Tablet should not be used during pregnancy due to the known risk to the developing baby. Only in life-threatening situations, a doctor may consider prescribing it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Caution is advised when using Nublexa Tablet while breastfeeding as it may be unsafe. Limited data suggests the drug could pass into breastmilk, potentially harming the baby.
Habit Forming | No |
Chemical Class | Diarylethers Derivative |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹36965
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025